ATC Group: C07AA23 Penbutolol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C07AA23 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C07 Beta blocking agents
3 C07A Beta blocking agents
4 C07AA Beta blocking agents, non-selective
5 C07AA23 Penbutolol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 40 mg

Active ingredients in C07AA23

Active Ingredient Description
Penbutolol

Penbutolol is a β-1, β-2 (nonselective) adrenergic receptor antagonist. The β-blocking potency of penbutolol is approximately 4 times that of propranolol. Penbutolol is used for the management of mild to moderate arterial hypertension, alone or in combination with other antihypertensive agents.

Medicines in this ATC group

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.